X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Unichem Lab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. UNICHEM LAB FDC LTD./
UNICHEM LAB
 
P/E (TTM) x 23.8 32.7 72.8% View Chart
P/BV x 5.0 3.4 144.1% View Chart
Dividend Yield % 1.0 0.6 172.9%  

Financials

 FDC LTD.   UNICHEM LAB
EQUITY SHARE DATA
    FDC LTD.
Mar-14
UNICHEM LAB
Mar-16
FDC LTD./
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs144334 43.0%   
Low Rs79174 45.4%   
Sales per share (Unadj.) Rs47.6146.9 32.4%  
Earnings per share (Unadj.) Rs7.611.9 64.0%  
Cash flow per share (Unadj.) Rs9.016.2 55.7%  
Dividends per share (Unadj.) Rs2.252.00 112.5%  
Dividend yield (eoy) %2.00.8 256.9%  
Book value per share (Unadj.) Rs47.5105.1 45.2%  
Shares outstanding (eoy) m177.8390.84 195.8%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x2.31.7 135.3%   
Avg P/E ratio x14.621.4 68.5%  
P/CF ratio (eoy) x12.315.7 78.7%  
Price / Book Value ratio x2.32.4 96.9%  
Dividend payout %29.616.8 175.8%   
Avg Mkt Cap Rs m19,78423,073 85.7%   
No. of employees `000NA5.7 0.0%   
Total wages/salary Rs m1,2212,558 47.7%   
Avg. sales/employee Rs ThNM2,352.5-  
Avg. wages/employee Rs ThNM450.9-  
Avg. net profit/employee Rs ThNM190.4-  
INCOME DATA
Net Sales Rs m8,45913,346 63.4%  
Other income Rs m394192 205.1%   
Total revenues Rs m8,85213,538 65.4%   
Gross profit Rs m2,0701,639 126.3%  
Depreciation Rs m249390 63.9%   
Interest Rs m3129 107.7%   
Profit before tax Rs m2,1841,412 154.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m-225-4 6,078.4%   
Extraordinary Inc (Exp) Rs m0-35 0.0%   
Tax Rs m606293 206.9%   
Profit after tax Rs m1,3531,080 125.2%  
Gross profit margin %24.512.3 199.3%  
Effective tax rate %27.720.7 133.8%   
Net profit margin %16.08.1 197.6%  
BALANCE SHEET DATA
Current assets Rs m4,3555,979 72.8%   
Current liabilities Rs m1,7922,432 73.7%   
Net working cap to sales %30.326.6 114.0%  
Current ratio x2.42.5 98.9%  
Inventory Days Days4463 70.5%  
Debtors Days Days2560 40.9%  
Net fixed assets Rs m3,0256,403 47.2%   
Share capital Rs m179182 98.3%   
"Free" reserves Rs m8,2439,293 88.7%   
Net worth Rs m8,4539,548 88.5%   
Long term debt Rs m11230 4.6%   
Total assets Rs m10,55712,843 82.2%  
Interest coverage x71.450.0 142.7%   
Debt to equity ratio x00 5.2%  
Sales to assets ratio x0.81.0 77.1%   
Return on assets %13.18.6 151.8%  
Return on equity %16.011.3 141.5%  
Return on capital %23.514.3 164.0%  
Exports to sales %13.329.2 45.5%   
Imports to sales %3.36.3 52.7%   
Exports (fob) Rs m1,1263,900 28.9%   
Imports (cif) Rs m283847 33.4%   
Fx inflow Rs m1,1464,356 26.3%   
Fx outflow Rs m3551,162 30.6%   
Net fx Rs m7913,194 24.8%   
CASH FLOW
From Operations Rs m1,4851,119 132.7%  
From Investments Rs m-620-853 72.6%  
From Financial Activity Rs m-753-334 225.2%  
Net Cashflow Rs m113-68 -165.2%  

Share Holding

Indian Promoters % 68.9 50.1 137.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 15.1 31.1%  
FIIs % 7.5 3.0 250.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 31.7 59.9%  
Shareholders   23,730 20,176 117.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  NOVARTIS  DR. DATSONS LABS  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Above 35,000 Mark; Bank & IT Stocks Outperform(Closing)

After opening the day flat, share markets in India witnessed positive trading activity throughout the day and ended the day on a strong note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jan 17, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - TTK HEALTHCARE COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS